Nuclear Diagnostics, Inc.

Nuclear Diagnostics, Inc. — FDA 510(k) Submissions

Nuclear Diagnostics, Inc. has submitted 22 FDA 510(k) premarket notifications since 1977, of which 22 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Radioimmunoassay, Thyroxine-binding Globulin, Radioimmunoassay, Total Thyroxine, Radioimmunoassay, Thyroid-stimulating Hormone, Radioassay, Triiodothyronine Uptake, Lipase-esterase, Enzymatic, Photometric, Lipase . Use the specialty filter in the sidebar to narrow results.